Marlies L van Bekkum

MRI-gestuurde personalisatie van neoadjuvante chemotherapieduur bij HER2+ vroeg mammacarcinoom: TRAIN-3

Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus tweedelijns for gevorderd breast cancer: ...

Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable...

Ribociclib-Letrozole Combination as an Alternative for Neoadjuvant Chemotherapy in Selected Postmenopausal Patients w...